Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-14
DOI
10.3389/fphar.2017.00808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway
- (2017) Rui Yang et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Andrographolide Benefits Rheumatoid Arthritis via Inhibiting MAPK Pathways
- (2017) Zun-zhong Li et al. INFLAMMATION
- Evodiamine attenuates TGF-β1-induced fibroblast activation and endothelial to mesenchymal transition
- (2017) Qing-Qing Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Andrographolide inhibits arrhythmias and is cardioprotective in rabbits
- (2017) Mengliu Zeng et al. Oncotarget
- Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells
- (2017) Aditi Banerjee et al. Oncotarget
- Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway
- (2017) Chen-wei Pan et al. Oncotarget
- Myofibroblasts and inflammatory cells as players of cardiac fibrosis
- (2016) Hitoshi Kurose et al. ARCHIVES OF PHARMACAL RESEARCH
- How cardiomyocytes sense pathophysiological stresses for cardiac remodeling
- (2016) Zaffar K. Haque et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cardiac Fibrosis
- (2016) Joshua G. Travers et al. CIRCULATION RESEARCH
- OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells
- (2016) Q.-Q. Wu et al. CLINICAL SCIENCE
- Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload
- (2016) Wei-ming Li et al. CLINICAL SCIENCE
- Mnk1 (Mitogen-Activated Protein Kinase–Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in MiceNovelty and Significance
- (2016) Yuan Yuan et al. HYPERTENSION
- Andrographis paniculata extract attenuates pathological cardiac hypertrophy and apoptosis in high-fat diet fed mice
- (2016) You-Liang Hsieh et al. JOURNAL OF ETHNOPHARMACOLOGY
- Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs)
- (2016) Ruijie Liu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Physiological and pathological cardiac hypertrophy
- (2016) Ippei Shimizu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK
- (2016) Siew Ying Wong et al. Journal of Neuroinflammation
- Andrographolide stimulates p38 mitogen-activated protein kinase–nuclear factor erythroid-2-related factor 2–heme oxygenase 1 signaling in primary cerebral endothelial cells for definite protection against ischemic stroke in rats
- (2016) Ting-Lin Yen et al. Translational Research
- Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways
- (2016) Tingfang Yang et al. Drug Design Development and Therapy
- Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-κB pathways
- (2016) Shuang Peng et al. Acta Pharmaceutica Sinica B
- Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway
- (2015) Qing-Qing Wu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway
- (2015) Yongmei Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Andrographolide Attenuates LPS-Induced Cardiac Malfunctions Through Inhibition of IκB Phosphorylation and Apoptosis in Mice
- (2015) Jinlong Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mechanotransduction in Cardiac Hypertrophy and Failure
- (2015) R. C. Lyon et al. CIRCULATION RESEARCH
- Bioavailability of andrographolide and protection against carbon tetrachloride-induced oxidative damage in rats
- (2014) Haw-Wen Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Parsing Good Versus Bad Signaling Pathways in the Heart
- (2013) Jeffery D. Molkentin CIRCULATION RESEARCH
- Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice
- (2012) Tamara P. Martin et al. EXPERIMENTAL PHYSIOLOGY
- Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets
- (2012) Jianglong Hou et al. PHARMACOLOGY & THERAPEUTICS
- Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II
- (2012) Feifei Ma et al. PLoS One
- Cardiac remodeling at the population level—risk factors, screening and outcomes
- (2011) Ola Gjesdal et al. Nature Reviews Cardiology
- Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
- (2011) Heng Zhou et al. PLoS One
- Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
- (2010) Izhak Kehat et al. Annals of the New York Academy of Sciences
- Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
- (2010) Beth A. Rose et al. PHYSIOLOGICAL REVIEWS
- Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts
- (2009) Xiuren Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation
- (2008) María D. Carretta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Andrographolide Up-Regulates Cellular-Reduced Glutathione Level and Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury
- (2008) A. Y. H. Woo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
- (2008) Kristina Lorenz et al. NATURE MEDICINE
- Cardiac Plasticity
- (2008) Joseph A. Hill et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started